Treatments for Plaque Psoriasis

The Value of Roflumilast Cream for Plaque Psoriasis
September 23, 2022

Roflumilast cream adds a much-needed element of simplicity for psoriasis patients and their dermatologists.

Why You Should You Be Prescribing Tapinarof for Plaque Psoriasis
September 10, 2022

At the Skin of Color Update meeting in New York City, Mona Shahriari, MD, FAAD, shares her thoughts on prescribing the recently-approved tapinarof (VTAMA) for plaque psoriasis.

Deucravacitinib Approved by FDA for Treatment of Psoriasis
September 10, 2022

Deucravacitinib offers new hope for those with moderate-to-severe plaque psoriasis.

Plaque Psoriasis Management: Future Directions in Care
February 07, 2022

Closing out their discussion on the management of plaque psoriasis, panelists share their excitement for future directions in care.

Biologic Therapy in Plaque Psoriasis: Treating During the COVID-19 Pandemic
February 07, 2022

Experts reflect on the treatment of patients with plaque psoriasis during the COVID-19 pandemic.

Unmet Needs in Moderate to Severe Plaque Psoriasis Management
January 31, 2022

A brief discussion on the unmet needs and ongoing challenges in the treatment of plaque psoriasis.

Plaque Psoriasis Patient Case 2: Factors in Selecting 2L Therapy
January 31, 2022

Shared insight on which factors are most important in determining second-line therapy for plaque psoriasis.

Plaque Psoriasis Patient Case 2: Switching Therapy at Treatment Failure
January 24, 2022

Moving on to the second patient case, panelists discuss switching therapy at treatment failure for plaque psoriasis.

Factors in Selecting Biologic Therapy for Moderate to Severe Plaque Psoriasis
January 24, 2022

Panelists share which factors they use to determine optimal therapy in the moderate to severe plaque psoriasis setting.

Plaque Psoriasis: Biologic Therapy Toxicity Profiles
January 17, 2022

A panel of experts reflect on the toxicity profiles of biologic agents used to treat patients with plaque psoriasis.